Stay updated on Maplirpacept in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Maplirpacept in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.3.3; the HHS Vulnerability Disclosure link was removed and Revision: v3.3.2 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T01:46:21.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The history shows a new Revision: v3.3.2 added and the previous Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T16:16:57.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the record history, and the revision v3.2.0 was removed. This reflects updates to the study's recorded version history.
    Difference
    0.1%
    Check dated 2025-11-23T14:54:59.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Removed the notice about government funding and operating status, an administrative banner that described potential delays and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T14:37:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Record history shows multiple updates to core content, including study status, contacts/locations, and study description, across numerous versions. The latest version indicates termination of the study by Pfizer with no safety concerns reported.
    Difference
    0.1%
    Check dated 2025-11-02T01:01:24.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated operating status notice and a new software version (v3.2.0) replacing the old v3.1.0.
    Difference
    9%
    Check dated 2025-10-04T12:28:50.000Z thumbnail image

Stay in the know with updates to Maplirpacept in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Maplirpacept in Hematologic Malignancies Clinical Trial page.